Saúde Pública/Medicina Humanitária

Um estudo de coorte de amplitude nacional na Dinamarca mostrou que a “long Covid” em crianças é rara e de curta duração.

31 Jan, 2022 | 09:00h

Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study – European Journal of Pediatrics

Conteúdos relacionados:

Editorial | Long covid in children and adolescents – “Risk appears low, but many questions remain”.

M-A: Persistent symptoms following SARS-CoV-2 infection among children and young people – “Higher study quality was associated with lower prevalence of all symptoms, except loss of smell and cognitive symptoms”.

Review: Long COVID symptoms in children rarely persist beyond three months.

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Do kids get long COVID? And how often? A pediatrician looks at the data – Children also get Long Covid, but much less often than adults.

Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.”

Long-term Symptoms After SARS-CoV-2 Infection in Children and Adolescents – “This study found a low prevalence of symptoms compatible with long COVID in a randomly selected cohort of children assessed 6 months after serologic testing”.

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

 

Comentário no Twitter

Absolutely HUGE study on persistent symptoms after #COVID19 ("long covid") in 37,000 children from Denmark 🇩🇰

Incidence 0.8% compared to controls

Most symptoms resolved in <5 months (often loss of smell/taste)

Reassuring news from biggest study yet✅https://t.co/vX2JFruOqe pic.twitter.com/GctgyMXn6I

— Alasdair Munro (@apsmunro) January 28, 2022

 

---

Apesar da contínua disseminação da Ômicron, alguns países europeus decidiram suspender os protocolos de restrições para Covid-19.

31 Jan, 2022 | 08:58h

England lifts COVID restrictions as omicron threat recedes – Associated Press

Denmark confirms plan to lift Covid-19 restrictions on February 1^st – The Local dk

Netherlands lifts toughest Covid curbs with Denmark and France set to follow – The Guardian

Denmark will lift nearly ALL Covid restrictions within days and return to ‘life as we knew it before corona’ after vaccine programme proved a ‘super-weapon’ – despite soaring cases – Daily Mail

 

Comentário no Twitter

IMMUNITY: Yes, UK dropped all COVID restrictions along with many countries in Europe following suit (masks optional, no vaccine passports, no asymptomatic testing) but that is due to high vax rates + Omicron infused immunity + advances in therapeuticshttps://t.co/fsbPkUqwSr

— Monica Gandhi MD, MPH (@MonicaGandhi9) January 28, 2022

 

---

Perspectiva | Em que ponto estamos com a Ômicron? Dados, cálculos, padrões e saída.

28 Jan, 2022 | 17:21h

Where do we stand with Omicron? – by Dr. Eric Topol

 

Comentário no Twitter

Where do we stand with Omicron?
I've summarized the new data, math, patterns, and potential exit ramphttps://t.co/SyCmCzkBQX @SubstackInc

— Eric Topol (@EricTopol) January 22, 2022

 

---

Estudo randomizado | Vacinação heteróloga de AD5-nCOV com CoronaVac vs. vacinação homóloga com CoronaVac.

28 Jan, 2022 | 17:20h

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial – Nature Medicine

Conteúdos relacionados:

RCT: Heterologous (Pfizer, J&J, or AstraZeneca) vs. homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil.

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination – Nature Medicine

WHO issues interim recommendations for heterologous COVID-19 vaccine schedules.

---

Após a Ômicron, alguns cientistas preveem “um período de calmaria”.

28 Jan, 2022 | 17:19h

After Omicron, some scientists foresee ‘a period of quiet’ – Science

---

Perspectiva | A variante Ômicron tornará imune a maioria de nós?

28 Jan, 2022 | 17:18h

Will Omicron Leave Most of Us Immune? – The Atlantic

---

Uma segunda versão da variante Ômicron está se disseminando. Este é o motivo de os cientistas estarem alertas.

28 Jan, 2022 | 17:16h

A second version of omicron is spreading. Here’s why scientists are on alert – NPR

Ver também: Scientists Watch, Worry About New ‘Stealth’ Version of Omicron Variant – HealthDay

---

Eles construíram uma abordagem mais inteligente para os estudos clínicos de Covid. Agora, eles querem fazer o mesmo para outras doenças.

28 Jan, 2022 | 17:15h

They built a smarter approach to Covid clinical trials. Now they want to do the same for other diseases – STAT

---

O lado positivo da moeda: a pandemia de SARS-CoV-2 nos ensinou sobre o quanto a telemedicina é útil como procedimento padrão de cuidado na vida real.

28 Jan, 2022 | 17:14h

The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life – Clinical Rheumatology

---

Casualidades da COVID: insulina e diálise – “Como a pandemia tem sido uma ameaça à vida de pessoas com diabetes e doença renal crônica.”

28 Jan, 2022 | 17:13h

Casualties of COVID: Insulin and Dialysis - Think Global Health

---